• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION CATH TEMPO 5F VER 135 DEGREE 100CM; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION CATH TEMPO 5F VER 135 DEGREE 100CM; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Model Number 451514H0
Device Problem Partial Blockage (1065)
Patient Problem Hemorrhage, Cerebral (1889)
Event Date 03/21/2019
Event Type  malfunction  
Manufacturer Narrative
The product was not returned for analysis.Device history record (dhr) review was conducted and the product met quality requirements for product acceptance.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
During a diagnostic cerebral angiography, a thrombus developed as soon as the guidewire was withdrawn from the catheter and the patient had a stroke on the table.The catheter became clogged in a few seconds.The customer changed the catheter with a non cordis catheter and the procedure was finished with success and patient was not injured.Decision from physician to withdraw catheter from shelf having same lot number.
 
Manufacturer Narrative
Additional information was received that the patient did not have a stroke.Therefore, the event type was revised to a malfunction.During a diagnostic cerebral angiography, a thrombus developed as soon as the guidewire was withdrawn from the catheter.The catheter became clogged in a few seconds.The customer changed the catheter with a non cordis catheter and the procedure was finished with success and patient was not injured.The product was not returned for analysis.A product history record (phr) review of lot 17797905 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿catheter (body/shaft) obstructed - in-patient¿ and ¿thrombus in catheter¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Procedural factors may have contributed to the reported event, as it is recommended that the patient should be considered for anticoagulation.According to the precautions in the safety information in the instructions for use ¿for all catheters: keep the catheter filled with either flushing solution or contrast medium while the catheter is in the vascular system and consider the use of systemic heparinization.Exercise care when removing guidewires from multiple-curve catheters.¿ neither the phr nor the limited information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CATH TEMPO 5F VER 135 DEGREE 100CM
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th ave,
miami lakes FL 33014
MDR Report Key8579303
MDR Text Key144012238
Report Number9616099-2019-02895
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
PMA/PMN Number
K973401
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2021
Device Model Number451514H0
Device Catalogue Number451514H0
Device Lot Number17797905
Was Device Available for Evaluation? No
Date Manufacturer Received05/31/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NACL 09.% LIQUEFIED; NACL 09.% LIQUEFIED
Patient Outcome(s) Life Threatening; Disability;
-
-